Expanding Profitability in Core Businesses
First written in FY2016. 21 of 39 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-13.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「In the titanium dioxide-related business, shipments of products for cosmetics and other applications increased, and higher sales prices also had a positive effect. As a result, segment net sales amounted to ¥4,981 million, up 8.1% from the previous consolidated fiscal year. Operating profit amounted to ¥108 million, compared with ¥1 million in the previous consolidated fiscal year, due to factors including the effect of higher sales prices and cost reductions.」
In the titanium dioxide-related business, higher shipments of products for cosmetics, price increases and cost reductions increased net sales 8.1% year on year and operating profit from ¥1 million to ¥108 million. - FY2026-H1AdvancedAnnual report
「In the titanium dioxide-related business, shipments of products for cosmetics and other applications increased, and higher sales prices also had a positive effect. As a result, segment net sales amounted to ¥2,527 million, up 8.5% year on year. However, due to factors including higher costs associated with lower production volumes, the operating loss was ¥5 million, compared with an operating loss of ¥20 million in the same period of the previous year.」
Higher shipments of products for cosmetics and other applications and higher sales prices resulted in higher net sales in the titanium dioxide-related business, while the operating loss narrowed from ¥20 million to ¥5 million. - FY2025-H1AdvancedAnnual report
「In the titanium dioxide-related business, shipments of products for lithium-ion secondary batteries and toner external additives increased as demand recovered. As a result, segment net sales amounted to ¥2,329 million, up 2.9% year on year. Despite higher sales prices, thorough cost reductions and the reversal of an inventory write-down, the Company recorded an operating loss of ¥20 million, compared with an operating loss of ¥170 million in the same period of the previous year.」
In the titanium dioxide-related business, shipments of battery products and toner external additives increased, with net sales up 2.9% year on year and the operating loss narrowing from ¥170 million to ¥20 million. - FY2024-Q3WorsenedAnnual report
「In the titanium dioxide-related business, shipments of products for toner external additives declined substantially due to weak demand. As a result, segment net sales amounted to ¥3,470 million, down 9.7% year on year. In addition to lower net sales, lower production volumes and persistently high prices for key raw materials and fuels resulted in an operating loss of ¥344 million, compared with operating profit of ¥256 million in the same period of the previous year.」
In the core titanium dioxide-related business, shipments of products for toner external additives declined substantially, with net sales down 9.7% year on year and operating results turning from profit to loss. - FY2024-Q2WorsenedAnnual report
「In the titanium dioxide-related business, shipments of products for toner external additives declined due to weak demand. Shipments of products for lithium-ion secondary batteries also declined due to factors including the semiconductor shortage. As a result, segment net sales amounted to ¥2,264 million, down 12.8% year on year. In addition to lower net sales, lower production volumes and persistently high prices for key raw materials and fuels resulted in an operating loss of ¥170 million, compared with operating profit of ¥177 million in the same period of the previous year.」
In the titanium dioxide-related business, shipments of products for toner external additives and batteries declined, resulting in lower net sales and a shift from operating profit to operating loss. - FY2024-Q1WorsenedAnnual report
「In the titanium dioxide-related business, shipments of products for lithium-ion secondary batteries declined due to factors including the semiconductor shortage. Shipments of products for toner external additives also declined due to weak demand. As a result, segment net sales amounted to ¥1,234 million, down 16.4% year on year. In addition to lower net sales, lower production volumes and persistently high prices for key raw materials and fuels resulted in an operating loss of ¥23 million, compared with operating profit of ¥148 million in the same period of the previous year.」
In the titanium dioxide-related business, shipments of products for batteries and toner external additives declined, with net sales down 16.4% year on year and operating results turning from profit to loss. - FY2023WorsenedAnnual report
「In the titanium dioxide-related business, the Company revised sales prices in response to soaring prices for key raw materials and fuels, but shipments of products for lithium-ion secondary batteries declined due to factors including the semiconductor shortage. As a result, segment net sales amounted to ¥5,338 million, down 2.3% from the previous consolidated fiscal year, and operating profit amounted to ¥368 million, down 9.8%, due to factors including lower net sales and soaring prices for key raw materials and fuels.」
Lower shipments of battery products and soaring raw material and fuel prices resulted in lower net sales and operating profit in the titanium dioxide-related business. - FY2023-Q3WorsenedAnnual report
「In the titanium dioxide-related business, the Company revised sales prices in response to soaring prices for key raw materials and fuels, but shipments of products for lithium-ion secondary batteries declined due to factors including the semiconductor shortage. As a result, segment net sales amounted to ¥3,844 million, down 1.8% year on year, and operating profit amounted to ¥256 million, down 24.2% year on year, due to factors including lower net sales and soaring prices for key raw materials and fuels.」
Although demand for toner external additives recovered and sales prices were revised, shipments of battery products declined due to factors including the semiconductor shortage, resulting in lower net sales and operating profit in the titanium dioxide-related business. - FY2023-Q2WorsenedAnnual report
「In the titanium dioxide-related business, shipments of products for lithium-ion secondary batteries declined due to factors including the semiconductor shortage. However, demand for products for toner external additives recovered as activity restrictions related to COVID-19 were eased, and the Company revised sales prices in response to soaring prices for key raw materials and fuels. As a result, segment net sales amounted to ¥2,597 million, up 1.6% year on year. Although recovering demand and sales-price revisions increased net sales, operating profit amounted to ¥177 million, down 24.7% year on year, due to factors including soaring prices for key raw materials and fuels.」
Although demand for toner external additives recovered and sales prices were revised, shipments of battery products declined due to the semiconductor shortage, resulting in a 24.7% year-on-year decline in operating profit in the titanium dioxide-related business. - FY2023-Q1AdvancedAnnual report
「In the titanium dioxide-related business, demand for products for toner external additives recovered as activity restrictions related to COVID-19 were eased, and the Company also revised sales prices in response to soaring prices for key raw materials and fuels. Shipments of products for lithium-ion secondary batteries also remained strong. As a result, segment net sales amounted to ¥1,476 million, up 10.1% year on year. Despite the impact of soaring prices for key raw materials and fuels, operating profit amounted to ¥148 million, up 3.2% year on year, due to factors including higher net sales from recovering demand and sales-price revisions, as well as lower costs resulting from higher production volumes.」
In the titanium dioxide-related business, recovering demand for toner external additives, sales-price revisions and strong shipments of products for lithium-ion secondary batteries resulted in net sales of ¥1,476 million and operating profit of ¥148 million. - FY2022AdvancedAnnual report
「Shipment volumes increased due to factors including recovering demand for products for toner external additives and UV-protection cosmetics as economic activity began to recover from the contraction caused by COVID-19, and strong shipments of products for lithium-ion secondary batteries. As a result, segment net sales amounted to ¥5,464 million, up 23.6% from the previous consolidated fiscal year, and operating profit amounted to ¥408 million, up 121.2%.」
In core areas, recovering demand for cosmetics and toner applications and strong shipments of products for lithium-ion secondary batteries resulted in higher net sales and operating profit than in the previous fiscal year. - FY2022-Q3AdvancedAnnual report
「Shipment volumes increased due to factors including recovering demand for products for toner external additives and UV-protection cosmetics as economic activity began to recover from the contraction caused by COVID-19, and strong shipments of products for lithium-ion secondary batteries. As a result, segment net sales amounted to ¥3,915 million, up 26.6% year on year. Despite the impact of higher depreciation expenses associated with the expansion of the ultrafine-particle titanium dioxide production facility and soaring prices for key raw materials and fuels, operating profit amounted to ¥338 million, up 357.9% year on year, due to factors including higher net sales and production volumes.」
In the titanium dioxide-related business, recovering demand for cosmetics and toner applications and strong shipments of battery products resulted in net sales of ¥3,915 million and operating profit of ¥338 million. - FY2022-Q2AdvancedAnnual report
「Shipment volumes increased due to factors including strong shipments of products for lithium-ion secondary batteries and recovering demand for products for UV-protection cosmetics and toner external additives as economic activity began to recover from the contraction caused by COVID-19. As a result, segment net sales amounted to ¥2,557 million, up 28.0% year on year. Despite the impact of higher depreciation expenses associated with the expansion of the ultrafine-particle titanium dioxide production facility and soaring prices for key raw materials and fuels, operating profit amounted to ¥235 million, up 230.5% year on year, due to factors including higher net sales and equipment utilization.」
Shipment volumes increased due to strong performance by battery products and recovering demand for products for UV-protection cosmetics and toner external additives, resulting in net sales of ¥2,557 million and operating profit of ¥235 million in the titanium dioxide-related business. - FY2022-Q1AdvancedAnnual report
「Shipment volumes increased due to factors including strong shipments of products for lithium-ion secondary batteries and recovering demand for products for UV-protection cosmetics and toner external additives as economic activity began to recover from the contraction caused by COVID-19. As a result, segment net sales amounted to ¥1,341 million, up 28.6% year on year. Despite the impact of higher depreciation expenses associated with the expansion of the ultrafine-particle titanium dioxide production facility and soaring prices for key raw materials and fuels, operating profit amounted to ¥143 million, up 21.4% year on year, due to factors including higher net sales and equipment utilization.」
In the titanium dioxide-related business, shipment volumes increased due to strong shipments of battery products and recovering demand for products for UV-protection cosmetics and toner external additives, resulting in net sales of ¥1,341 million and operating profit of ¥143 million. - FY2021WorsenedAnnual report
「In the titanium dioxide-related business, demand for products for UV-protection cosmetics and toner external additives declined substantially due to the rapid contraction of economic activity caused by the global COVID-19 pandemic. As a result, segment net sales amounted to ¥4,420 million, down 34.1% from the previous consolidated fiscal year, and operating profit amounted to ¥184 million, down 71.3%.」
Demand in core areas continued to decline throughout the fiscal year, with net sales in the titanium dioxide-related business down 34.1% year on year and operating profit down 71.3%. - FY2021-Q3WorsenedAnnual report
「In the titanium dioxide-related business, demand for products for UV-protection cosmetics and toner external additives declined substantially due to the rapid contraction of economic activity caused by the global COVID-19 pandemic. As a result, segment net sales amounted to ¥3,092 million, down 38.6% year on year, and operating profit amounted to ¥73 million, down 82.6% year on year.」
Demand for products in the core business continued to decline, with net sales in the titanium dioxide-related business down 38.6% year on year and operating profit down 82.6%. - FY2021-Q2WorsenedAnnual report
「In the titanium dioxide-related business, demand for products for UV-protection cosmetics and toner external additives declined substantially due to the rapid contraction of economic activity caused by the global COVID-19 pandemic. As a result, segment net sales amounted to ¥1,997 million, down 34.7% year on year, and operating profit amounted to ¥71 million, down 78.9% year on year.」
Demand for products in the core business continued to decline, with net sales in the titanium dioxide-related business down 34.7% year on year and operating profit down 78.9%. - FY2021-Q1Sharp decline in demand for functional products due to COVID-19Annual report
「In the titanium dioxide-related business, demand for products for UV-protection cosmetics and toner external additives declined substantially due to the rapid contraction of economic activity caused by the global COVID-19 pandemic. As a result, segment net sales amounted to ¥1,042 million and operating profit to ¥118 million.」
In the core titanium dioxide-related business, demand for products for UV-protection cosmetics and toner external additives declined substantially due to the impact of COVID-19. Segment net sales amounted to ¥1,042 million and operating profit to ¥118 million. - FY2020AdvancedAnnual report
「The titanium dioxide-related business worked to expand sales of functional titanium dioxide products. As a result, segment net sales amounted to ¥6,712 million and operating profit to ¥642 million.」
The Company expanded sales of functional titanium dioxide products, recording full-year net sales of ¥6,712 million and operating profit of ¥642 million. - FY2020-Q3AdvancedAnnual report
「The Company worked to expand sales of functional titanium dioxide products. As a result, segment net sales amounted to ¥5,039 million and operating profit to ¥425 million.」
The Company continued to expand sales of functional titanium dioxide products, recording net sales of ¥5,039 million and operating profit of ¥425 million in the cumulative third quarter of the consolidated fiscal year. - FY2020-Q2AdvancedAnnual report
「(Titanium dioxide-related business) The titanium dioxide-related business worked to expand sales of functional titanium dioxide products. As a result, segment net sales amounted to ¥3,061 million and operating profit to ¥338 million.」
The Company continued to expand sales of functional titanium dioxide products, recording net sales of ¥3,061 million and operating profit of ¥338 million in the cumulative second quarter of the consolidated fiscal year. - FY2020-Q1AdvancedAnnual report
「Shipment volumes of functional titanium dioxide products increased substantially due to factors including the adoption of new products for UV-protection cosmetics and toner applications and strong performance by products for batteries used in automobiles and other applications. As a result, segment net sales amounted to ¥1,493 million, up 11.4% year on year. Despite soaring raw material and fuel prices, operating profit amounted to ¥195 million, up 46.5% year on year, due to factors including higher net sales.」
The adoption of new products and strong performance by products for batteries used in automobiles and other applications led to a substantial increase in shipments of functional titanium dioxide products, while net sales and operating profit in the titanium dioxide-related business both exceeded the same period of the previous year. - FY2019AdvancedAnnual report
「Shipment volumes of functional titanium dioxide products increased substantially due to factors including the adoption of new products for UV-protection cosmetics and toner applications and strong performance by products for batteries used in automobiles and other applications. As a result, segment net sales amounted to ¥5,893 million, up 32.4% from the previous fiscal year. Despite soaring raw material and fuel prices, operating profit amounted to ¥479 million, up 911.5% from the previous fiscal year, due to factors including the substantial increase in net sales and higher equipment utilization.」
The adoption of new products and strong performance by battery products led to a substantial increase in shipments in the titanium dioxide-related business, with significant increases in both net sales and operating profit. - FY2019-Q3AdvancedAnnual report
「Shipment volumes of titanium dioxide increased due to factors including higher exports. Shipment volumes of functional titanium dioxide products increased substantially due to factors including the adoption of new products for UV-protection cosmetics and toner applications and strong performance by products for batteries used in automobiles. As a result, segment net sales amounted to ¥4,300 million, up 35.0% year on year. Despite soaring raw material and fuel prices, operating profit amounted to ¥348 million, compared with an operating loss of ¥39 million in the same period of the previous year, due to factors including the substantial increase in net sales and higher equipment utilization.」
The adoption of new products for UV-protection cosmetics and toner applications, together with strong performance by battery products, led to a substantial increase in shipments in the titanium dioxide-related business, improving both net sales and operating profit from the same period of the previous year. - FY2019-Q2AdvancedAnnual report
「Shipment volumes of functional titanium dioxide products increased substantially due to factors including the adoption of new products for UV-protection cosmetics and strong performance by products for batteries used in automobiles.」
Shipment volumes of functional products increased substantially due to the adoption of new products for UV-protection cosmetics and strong performance by products for batteries used in automobiles. The titanium dioxide-related business recorded net sales of ¥2,691 million and operating profit of ¥212 million. - FY2019-Q1AdvancedAnnual report
「Shipment volumes of functional titanium dioxide products and iron oxide increased substantially. As a result, net sales for the cumulative first quarter amounted to ¥1,915 million, up 22.5% year on year and substantially above the same period of the previous year.」
Shipment volumes in core areas, including functional titanium dioxide products, increased substantially, and total net sales rose 22.5% year on year. - FY2018RestatedAnnual report
「Shipment volumes of the core business's ultrafine-particle titanium dioxide increased substantially due to factors including the adoption of new products for UV-protection cosmetics.」
The Company continued to report higher shipments of ultrafine-particle titanium dioxide through the adoption of new products for the full year. - FY2018-Q3AdvancedAnnual report
「The Company has positioned ultrafine-particle titanium dioxide as a core business and has worked diligently to develop new products and expand sales of existing products. In July 2017, the ST-4 plant underwent a GMP inspection by the FDA (U.S. Food and Drug Administration) and was approved as an OTC drug-substance manufacturing facility for ultrafine-particle titanium dioxide used in UV-protection cosmetics. Strong demand from overseas is therefore expected going forward. Accordingly, the Company planned to expand the ST-5 ultrafine-particle titanium dioxide production facility to increase the scale of the business. The investment is expected to total approximately ¥1 billion, with construction scheduled to begin in March 2018 and production scheduled to start in October of the same year.」
Following the FDA's GMP inspection, the ST-4 plant was approved as an OTC drug-substance manufacturing facility. The plan to expand the ST-5 plant in anticipation of overseas demand was also presented with specific details: investment of approximately ¥1 billion, construction starting in March 2018 and production starting in October of the same year. - FY2018-Q2AdvancedAnnual report
「Shipment volumes of the core business's ultrafine-particle titanium dioxide increased due to factors including the adoption of new products for UV-protection cosmetics.」
The Company states that shipment volumes of ultrafine-particle titanium dioxide increased following the adoption of new products for UV-protection cosmetics. - FY2018-Q1RestatedAnnual report
「Against this backdrop, under the three-year new medium-term business plan (fiscal years ending March 2016 to March 2018), we worked to strengthen our earnings base for sustainable growth by rebuilding our core businesses, expanding earnings from our core businesses and strengthening new businesses.」
The Company continues its policy of expanding earnings from its core businesses. New ultrafine-particle titanium dioxide products performed steadily, while the shipping schedule for existing products shifted to the second quarter or later. - FY2017RestatedAnnual report
「Expanding earnings from core businesses Expanding earnings through the early launch of new products and global business expansion」
The Company continues to pursue its basic strategy of expanding earnings from ultrafine-particle titanium dioxide, its core business. - FY2017-Q3AdvancedAnnual report
「Shipment volumes of both new and existing ultrafine-particle titanium dioxide products increased steadily, but shipments of lithium titanate declined sharply. As a result, net sales for the cumulative first nine months amounted to ¥4,590 million, down 2.5% year on year.」
The Company states that shipment volumes of ultrafine-particle titanium dioxide increased steadily for both new and existing products. However, total net sales fell 2.5% year on year. - FY2017-Q2RestatedAnnual report
「Shipment volumes of the core business's ultrafine-particle titanium dioxide increased following decisions to adopt new products for toner external additives and UV-protection cosmetics.」
The Company again reports decisions to adopt new products and higher shipment volumes, but identifies no new achievement milestones from the previous quarter. - FY2017-Q1AdvancedAnnual report
「Although the Company achieved results including decisions to adopt new ultrafine-particle titanium dioxide products, shipments of existing products decreased. As a result, net sales for the cumulative first quarter amounted to ¥1,551 million, down 1.2% year on year and below the same period of the previous year.」
The Company reports the specific achievement of having new ultrafine-particle titanium dioxide products selected for adoption. However, total net sales fell below the same period of the previous year due to lower shipment volumes of existing products. - FY2016First statedAnnual report
「Expanding earnings from core businesses Expanding earnings through the early launch of new products and global business expansion」
The Company positions ultrafine-particle titanium dioxide as a core business and presents it in connection with its policy of expanding earnings.